New! View global litigation for patent families

US20030174375A1 - Readjustable optical elements - Google Patents

Readjustable optical elements Download PDF

Info

Publication number
US20030174375A1
US20030174375A1 US10324540 US32454002A US2003174375A1 US 20030174375 A1 US20030174375 A1 US 20030174375A1 US 10324540 US10324540 US 10324540 US 32454002 A US32454002 A US 32454002A US 2003174375 A1 US2003174375 A1 US 2003174375A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
element
optical
polymer
mc
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10324540
Other versions
US6851804B2 (en )
Inventor
Jagdish Jethmalani
Shiao Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rxsight Inc
Original Assignee
Calhoun Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/46Polymerisation initiated by wave energy or particle radiation
    • C08F2/48Polymerisation initiated by wave energy or particle radiation by ultra-violet or visible light
    • C08F2/50Polymerisation initiated by wave energy or particle radiation by ultra-violet or visible light with sensitising agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F290/00Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
    • C08F290/02Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
    • C08F290/06Polymers provided for in subclass C08G
    • C08F290/068Polysiloxanes
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS, OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made
    • G02B1/04Optical elements characterised by the material of which they are made made of organic materials, e.g. plastics
    • G02B1/041Lenses
    • G02B1/043Contact lenses
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C2202/00Generic optical aspects applicable to one or more of the subgroups of G02C7/00
    • G02C2202/14Photorefractive lens material

Abstract

The invention relates to optical elements whose optical properties can be repeatedly adjusted over time. Through the use of modifying compositions capable of stimulus induced polymerization coupled with a blend of stimulus absorbers and initiators, it is possible to repeatedly adjust the optical properties of the element by exposing the lens to a stimulus which exceeds the absorption capacity of the stimulus absorber.

Description

  • [0001]
    The present application claims the benefit of the priority data in U.S. application Ser. No. 60/344,182, filed Dec. 28, 2001.
  • BRIEF SUMMARY OF THE INVENTION
  • [0002]
    The invention relates to optical elements whose optical properties can be readjusted over extended periods of time. In one embodiment, an intraocular lens is provided whose optical properties can be changed multiple times after implantation.
  • BACKGROUND OF THE INVENTION
  • [0003]
    Approximately two million cataract surgery procedures are performed in the United States annually. The procedure generally involves making an incision in the anterior lens capsule to remove the cataractous crystalline lens and implanting an intraocular lens in its place. The power of the implanted lens is selected (based upon pre-operative measurements of ocular length and corneal curvature) to enable the patient to see without additional corrective measures (e.g., glasses or contact lenses). Unfortunately, due to errors in measurement, and/or variable lens positioning and wound healing, about half of all patients undergoing this procedure will not enjoy optimal vision without correction after surgery. Brandser et al, Acta Ophthalmol Scand 75:162-165 (1997); Oshika et al., J. Cataract Refract Surg 24:509-514 (1998). Because the power of prior art intraocular lenses generally cannot be adjusted once they have been implanted, the patient typically must choose between replacing the implanted lens with another lens of a different power or be resigned to the use of additional corrective lenses such as glasses or contact lenses. Since the benefits typically do not outweigh the risks of the former, it is almost never done.
  • [0004]
    Recently, a new type of intraocular lens has been described which permits post-operative manipulation of the optical properties of the lens. This allows for post-operative adjustment of the lens to achieve optimal vision quality for the patient. The post-operative manipulation is accomplished through the polymerization of modifying composition (“MC”) in specific regions of the lens by external stimuli, such as light. By polymerizing the MC in specific regions, the optical qualities of the lens can be adjusted until the desired optical properties are achieved. To prevent further changes in the optical properties, however, any remaining MC is then polymerized throughout the lens, “locking-in” the properties.
  • [0005]
    Unfortunately, this prevents further adjustment of the lens at a later time. For example, if the lens were implanted in a child, it would not be possible to readjust the lens to compensate for changes in vision due to aging or the like. In this case, the patient would have to choose between surgery to replace the lens or to use other corrective devices, e.g., glasses.
  • [0006]
    Thus, a need exists for an intraocular lens whose optical properties can be adjusted on more than one occasion.
  • SUMMARY OF THE INVENTION
  • [0007]
    The invention relates to optical elements whose optical properties can be modified post-fabrication and adjusted multiple times. In a specific embodiment, an intraocular lens is provided whose optical properties can be adjusted post-implantation more than once.
  • [0008]
    The optical properties of the elements are adjusted by the localized stimulus-induced polymerization of a modifying composition (“MC”) which is dispersed in the optical element. When the MC is polymerized in a specific region of the element, the optical properties of the element are changed, This is accomplished by changing the refractive index of the element in the area where polymerization has occurred, or by changing the shape of the element, or both. One key aspect of the invention is that this is accomplished with the addition or removal of material from the element.
  • [0009]
    As noted above, the polymerization of the MC is stimulus-induced. Typically, this refers to photopolymerization; however, other external stimuli may be used. The stimulus-induced polymerization is caused by the presence of one or more initiators which, when exposed to the proper stimulus, induces or initiates polymerization of the MC.
  • [0010]
    The invention relates to controlling the conditions under which the initiators start polymerization of the MC. It has been found that through the use of various stimulus-absorbing compounds combined with initiator compounds, it is possible to control the conditions under which the polymerization reaction occurs. Thus, it is possible to control the conditions such that any external stimuli present in the normal environment encountered by the element will not cause polymerization of the MC.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0011]
    [0011]FIG. 1 is a plot of light intensity versus wave length showing the levels for ambient sunlight and the ANSI MPE level.
  • [0012]
    [0012]FIG. 2 is a plot of UV absorber versus wave length for a UV absorber and initiator combination useful in practice of the invention.
  • [0013]
    [0013]FIG. 3 is a cross section of a portion of an optical element of the invention.
  • [0014]
    [0014]FIG. 4 is a cross section of an optical element of the present invention upon exposure to UV light.
  • [0015]
    [0015]FIG. 5 is a cross section of a portion of an optical element of the invention after exposure to UV light.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0016]
    The invention relates to optical elements whose optical properties can be continuously modified or adjusted over its useful life. This adjustment is accomplished in a self-contained system that is without the addition or removal of material from the element.
  • [0017]
    Typical optical elements within the scope of the invention include data storage elements, including compact disks, digital video disks; lenses, including but not limited to spectacle lenses; contact lenses, intraocular lenses; mirrors, prisms, and the like. In the preferred embodiment, the optical element is an intraocular lens.
  • [0018]
    The optical element is typically prepared from a first polymer matrix which gives shape to the element as well as many of its physical properties such as hardness, flexibility and the like.
  • [0019]
    The optical element also contains a MC dispersed therein. This MC may be a single compound or a combination of compounds that is capable of stimulus-induced polymerization, preferably photopolymerization.
  • [0020]
    The nature of the first polymer matrix and the MC will vary depending upon the end use contemplated for the optical element. However, as a general rule, the first polymer matrix and the MC are selected such that the components that comprise the MC are capable of diffusion within the first polymer matrix. Put another way, a loose first polymer matrix will tend to be paired with larger MC components and a tight first polymer matrix will tend to be paired with smaller MC components.
  • [0021]
    Upon exposure to an appropriate energy (e.g., heat or light), the MC typically forms a second polymer matrix in the exposed region of the optical element. The presence of the second polymer matrix changes the material characteristics of this portion of the optical element to modulate its refraction capabilities. In general, the formation of the second polymer matrix typically increases the refractive index of the affected portion of the optical element. After exposure, the MC in the unexposed region will migrate into the exposed region over time. The amount of MC migration into the exposed region is time dependent and may be precisely controlled. If enough time is permitted, the MC components will re-equilibrate and redistribute throughout optical element (i.e., the first polymer matrix, including the exposed region). When the region is re-exposed to the energy source, the MC that has since migrated into the region (which may be less than if the MC were allowed to re-equilibrate) polymerizes to further increase the formation of the second polymer matrix. This process (exposure followed by an appropriate time interval to allow for diffusion) may be repeated until the exposed region of the optical element has reached the desired property (e.g., power, refractive index, or shape). At this point, because of the presence of the UV absorber, no further polymerization occurs until the element is exposed to the specific wave length and intensity. Thus, in the case of an intraocular lens, the lens may be exposed to natural light and the like without further changes in the lens. If adjustment are needed because of aging or changes in the patient's health, for example, the lens can be adjusted by exposure to an appropriate energy source.
  • [0022]
    The first polymer matrix is a covalently or physically linked structure that functions as an optical element and is formed from a first polymer matrix composition (“FPMC”). In general, the first polymer matrix composition comprises one or more monomers that upon polymerization will form the first polymer matrix. The first polymer matrix composition optionally may include any number of formulation auxiliaries that modulate the polymerization reaction or improve any property of the optical element. Illustrative examples of suitable FPMC monomers include acrylics, methacrylates, phosphazenes, siloxanes, vinyls, homopolymers and copolymers thereof. As used herein, a “monomer” refers to any unit (which may itself either be a homopolymer or copolymer) which may be linked together to form a polymer containing repeating units of the same. If the FPMC monomer is a copolymer, it may be comprised of the same type of monomers (e.g., two different siloxanes) or it may be comprised of different types of monomers (e.g., a siloxane and an acrylic).
  • [0023]
    In one embodiment, the one or more monomers that form the first polymer matrix are polymerized and cross-linked in the presence of the MC. In another embodiment, polymeric starting material that forms the first polymer matrix is cross-linked in the presence of the MC. Under either scenario, the MC components must be compatible with and not appreciably interfere with the formation of the first polymer matrix. Similarly, the formation of the second polymer matrix should also be compatible with the existing first polymer matrix. Put another way, the first polymer matrix and the second polymer matrix should not phase separate and light transmission by the optical element should be unaffected.
  • [0024]
    As described previously, the MC may be a single component or multiple components so long as: (i) it is compatible with the formation of the first polymer matrix; (ii) it remains capable of stimulus-induced polymerization after the formation of the first polymer matrix: and (iii) it is freely diffusable within the first polymer matrix. In preferred embodiments, the stimulus-induced polymerization is photo-induced polymerization.
  • [0025]
    In general, there are two types of intraocular lenses (“IOLs”). The first type of an intraocular lens replaces the eye's natural lens. The most common reason for such a procedure is cataracts. The second type of intraocular lens supplements the existing lens and functions as a permanent corrective lens. This type of lens (sometimes referred to as a phakic intraocular lens) is implanted in the anterior or posterior chamber to correct any refractive errors of the eye. In theory, the power for either type of intraocular lenses required for emmetropia (i.e., perfect focus on the retina from light at infinity) can be precisely calculated. However, in practice, due to errors in measurement of corneal curvature, and/or variable lens positioning and wound healing, it is estimated that only about half of all patients undergoing IOL implantation will enjoy the best possible vision without the need for additional correction after surgery. Because prior art IOLs are generally incapable of post-surgical power modification, the remaining patients must resort to other types of vision correction such as external lenses (e.g. glasses or contact lenses) or cornea surgery. The need for these types of additional corrective measures is obviated with the use of the intraocular lenses of the present invention.
  • [0026]
    The inventive intraocular lens comprises a first polymer matrix and a MC dispersed therein. The first polymer matrix and the MC are as described above with the additional requirement that the resulting lens be biocompatible.
  • [0027]
    Illustrative examples of a suitable first polymer matrix include: polyacrylates such as polyalkyl acrylates and polyhydroxyalkyl acrylates; polymethacrylates such as polymethyl methacrylate (“PMMA”), a polyhydroxyethyl methacrylate (“PHEMA”), and polyhydroxypropyl methacrylate (“HPMA”); polyvinyls such as polystyrene and polyvinylpyrrolidone (“NVP”); polysiloxanes such as polydimethylsiloxane; polyphosphazenes, and copolymers of thereof. U.S. Pat. No. 4,260,725 and patents and references cited therein (which are all incorporated herein by reference) provide more specific examples of suitable polymers that may be used to form the first polymer matrix.
  • [0028]
    In preferred embodiments, the first polymer matrix generally possesses a relatively low glass transition temperature (“Tg”) such that the resulting IOL tends to exhibit fluid-like and/or elastomeric behavior. In applications where flexibility is important (e.g., intraocular lenses or contact lenses), the Tg will generally be less than 25° C. preferably less than 20° C. Where rigidity is important, the Tg will be much higher, e.g., 25° C. to 50° C.
  • [0029]
    The first polymer matrix is typically formed by cross-linking one or more polymeric starting materials wherein each polymeric starting material includes at least one cross-linkable group. Illustrative examples of suitable cross-linkable groups include but are not limited to hydride, acetoxy, alkoxy, amino, anhydride, aryloxy, carboxy, enoxy, epoxy, halide, isocyano, olefinic, and oxine. In more preferred embodiments, each polymeric starting material includes terminal monomers (also referred to as endcaps) that are either the same or different from the one or more monomers that comprise the polymeric starting material but include at least one cross-linkable group. In other words, the terminal monomers begin and end the polymeric starting material and include at least one cross-linkable group as part of its structure. Although it is not necessary for the practice of the present invention, the mechanism for cross-linking the polymeric starting material preferably is different than the mechanism for the stimulus-induced polymerization of the components that comprise the MC. For example, if the MC is polymerized by photo-induced polymerization, then it is preferred that the polymeric starting materials have cross-linkable groups that are polymerized by any mechanism other than photo-induced polymerization.
  • [0030]
    An especially preferred class of polymeric starting materials for the formation of the first polymer matrix is polysiloxanes (also known as “silicones”) endcapped with a terminal monomer which includes a cross-linkable group selected from the group consisting of acetoxy, amino, alkoxy, halide, hydroxy, and mercapto. Because silicone IOLS tend to be flexible and foldable, generally smaller incisions may be used during the IOL implantation procedure. An example of an especially preferred polymeric starting material is bis(diacetoxymethylsilyl)-polydimethysiloxane (which is polydimethylsiloxane that is endcapped with a diacetoxymethylsilyl terminal monomer).
  • [0031]
    The MC that is used in fabricating IOLs is as described above except that it has the additional requirement of biocompatibility. The MC is capable of stimulus-induced polymerization and may be a single component or multiple components so long as: (i) it is compatible with the formation of the first polymer matrix; (ii) it remains capable of stimulus-induced polymerization after the formation of the first polymer matrix; and (iii) it is freely diffusable within the first polymer matrix. In general, the same type of monomers that is used to form the first polymer matrix may be used as a component of the MC. However, because of the requirement that the MC monomers must be diffusable within the first polymer matrix, the MC monomers generally tend to be smaller (i.e., have lower molecular weights) than the monomers which form the first polymer matrix. In addition to the one or more monomers, the MC may include other components such as initiators and sensitizers that facilitate the formation of the second polymer matrix.
  • [0032]
    Because of the preference for flexible and foldable IOLs, an especially preferred class of MC monomers is polysiloxanes endcapped with a terminal siloxane moiety that includes a photopolymerizable group. An illustrative representation of such a monomer is:
  • X—Y—X1
  • [0033]
    wherein Y is a siloxane which may be a monomer, a homopolymer or a copolymer formed from any number of siloxane units, and X and X1 may be the same or different and are each independently a terminal siloxane moiety that includes a photopolymerizable group. Illustrative examples of Y include:
    Figure US20030174375A1-20030918-C00001
  • [0034]
    wherein: m and n are independently each an integer and
  • [0035]
    R1, R2, R3, and R4, are independently each hydrogen, alkyl (primary, secondary, tertiary, cyclo), aryl, or heteroaryl. In preferred embodiments, R1, R2, R3, and R4, is a C1-C10 alkyl or phenyl. Because MC monomers with a relatively high aryl content have been found to produce larger changes in the refractive index of the inventive lens, it is generally preferred that at least one of R1, R2, R3, and R4 is an aryl, particularly phenyl. In more preferred embodiments. R1, R2, R3 are the same and are methyl, ethyl or propyl and R4 is phenyl.
  • [0036]
    Illustrative examples of X and X1 (or X1 and X depending on how the MC polymer is depicted) are:
    Figure US20030174375A1-20030918-C00002
  • [0037]
    respectively wherein:
  • [0038]
    R5 and R6 are independently each hydrogen, alkyl, aryl, or heteroaryl; and Z is a photopolymerizable group.
  • [0039]
    In preferred embodiments R1 and R6 are independently each a C1 and C10 alkyl or phenyl and Z is a photopolymerizable group that includes a moiety selected from the group consisting of acrylate, allyloxy, cinnamoyl, methacrylate, stibenyl, and vinyl. In more preferred embodiments, R5 and R6 is methyl, ethyl, or propyl and Z is a photopolymerizable group that includes an acrylate or methacrylate moiety.
  • [0040]
    In especially preferred embodiments, an MC monomer is of the following formula:
    Figure US20030174375A1-20030918-C00003
  • [0041]
    wherein X and X1 are the same and R1, R2, R3, and R4 are as defined previously. Illustrative examples of such MC monomers include dimethylsiloxane-diphenylsiloxane copolymer endcapped with a vinyl dimethylsilane group; dimethylsiloxane-methylphenylsiloxane copolymer endcapped with a methacryloxypropyl dimethylsilane group; and dimethylsiloxane endcapped with a methacryloxypropyldimethylsilane group. Although any suitable method may be used, a ring-opening reaction of one of more cyclic siloxanes in the presence of triflic acid has been found to be a particularly efficient method of making one class of inventive MC monomers. Briefly, the method comprises contacting a cyclic siloxane with a compound of the formula:
    Figure US20030174375A1-20030918-C00004
  • [0042]
    in the presence of triflic acid wherein R5, R6, and Z are as defined previously. The cyclic siloxane may be a cyclic siloxane monomer, homopolymer, or copolymer. Alternatively, more than one cyclic siloxane may be used. For example, a cyclic dimethylsiloxane tetramer and a cyclic methyl-phenylsiloxane trimer are contacted with bismethacryloxypropyltetramethyldisiloxane in the presence of triflic acid to form a dimethyl-siloxane methyl-phenylsiloxane copolymer that is endcapped with a methacryloxylpropyl-dimethylsilane group, an especially preferred MC monomer.
  • [0043]
    As discussed above, the stimulus-induced polymerization requires the presence of an initiator. The initiator is such that upon exposure to a specific stimuli, it induces or initiates the polymerization of the MC. In the preferred embodiment, the initiator is a photoinitiator. The photoinitiator may also be associated with a sensitizer. Examples of photoinitiators suitable for use in the practice of the invention are acetophenones (e.g., substituted haloaceto phenones and diethoxyacetophenone); 2, 4-dichloromethyl-1,3,5-triazines; benzoin methyl ether; and O-benzoyl oximino ketone.
  • [0044]
    Suitable sensitizers include p-(dialkylamino aldehyde); n-alkylindolylidene; and bis [p-(dialkyl amino) benzylidene] ketone.
  • [0045]
    Alternatively, the MC of the invention may comprise multifunctional acrylate based monomers having the general formula:
  • X-(A)m-Q-(A)m-X1
  • [0046]
    or
  • X-(A)n-(A1)m-Q-(A)m-(A1)n-X1
  • [0047]
    wherein Q is an acrylate based compound used to create the acrylate monomer; A and A1 are the same or different and have the general structure:
    Figure US20030174375A1-20030918-C00005
  • [0048]
    wherein R7 and R8 are alkly, haloalkyl, aryl, haloaryl, and X and X1 contain moieties capable of stimulus induced polymigration, preferably photopolymerizable groups and N and M are integers.
  • [0049]
    In one embodiment the macromer has the general structure
    Figure US20030174375A1-20030918-C00006
  • [0050]
    wherein R9 R10 and R11a are independently selected from the group consisting of alkyls, haloalkyls, aryls, and haloaryls and n and m are integers and X and X1 are as defined above.
  • [0051]
    Another key component of the invention is a stimulus absorbing compound. These compounds regulate the level of external stimulus needed to initiate the polymerization of the MC.
  • [0052]
    In the preferred embodiment, the stimulus-absorbing compound is a light-absorbing compound, more preferably a UV absorber. UV absorbers useful in the practice of this invention include benzotriazole compounds having the general formula:
    Figure US20030174375A1-20030918-C00007
  • [0053]
    and mixtures thereof, wherein X is selected from the group consisting of H, alkoxy radicals preferably containing 1 to about 6 carbon atoms, and halogen, R1 is selected from the group consisting of H and alkyl radicals, preferably containing 1 to about 8 carbon atoms, provided that at least one of X and R1 is other than H, and R2 is an organic radical, preferably an alkenyl radical, with a terminal double bond. The alkoxy radical is preferably selected from the group consisting of methyl radical and t-alkyl radicals containing 4 to about 6 carbon atoms. The present compositions, including the covalently bonded ultraviolet light absorbing component preferably are capable of absorbing ultraviolet light in the range of about 300 nm. to about 400 nm.
  • [0054]
    As with the photoabsorber, the preferred photoinitiator useful in the practice of the invention are UV-sensitive photoinitiators. Particularly preferred photoinitiators are x-alkyl/benzoins having the general formula or structure:
    Figure US20030174375A1-20030918-C00008
  • [0055]
    wherein R1 is H, alkyl radical, aryl radical, substituted alkyl, or substituted aryl radical, and R2 is H, alkyl radical, aryl radical, substituted alkyl or substituted aryl radical; R3 and R4 are phenyl or substituted phenyl. Specific examples of R4 and R2 groups include methyl, phenyl trifluoropropyl, ethyl and cyano propyl. Phenyl substituents from the R3 and R4 groups may include alkyl, alkoxy, halogen, alkyaryl, cyano alkyl, haloalkyl and N, N dialkyl amino. Photoinitiator useful in the practice of the invention include Irgacure 819, Irgacure 184, Irgacure 369 and Irgacure 651 all available from Ciba Specialty Chemicals Inc. Where clarity is required, such as in optical elements, Irgacure 651 is preferred.
  • [0056]
    Also useful in the practice of the invention are photoinititators having two initiators linker by a short polymer backbone. One such compound is Benzoin polydimethyl siloxane Benzoin (B-pdms-B) wherein two benzoin moieties are linked by a dimethyl siloxane bridge. The compound has the general formula:
    Figure US20030174375A1-20030918-C00009
  • [0057]
    Synthesis of these compounds is described in U.S. Pat. No. 4,477,326, the teachings of which are incorporated by reference for United States practice.
  • [0058]
    The relative amounts of UV absorber and initiator will vary depending upon the desire degree of absorbence for the specific application. Generally the ratio of photoinitiator to UV absorber will range from about 6:1 to about 25:1. Generally, the relative amounts of photoinitiator and UV absorber can be calculated using the formula:
  • cos T=A=E 1 b 1 c 1 +E 2 b 2 c 2
  • [0059]
    wherein T is transmittance, A is absorbence, E1 is the extinction coefficient for the UV absorber, b1 is the path length of the light and c1 is the concentration of the UV absorber. E2, b2, and c2 are as defined above except that they relate to the photoinitiator. In practice, it has been found that the actual absorbence is generally less than the predicted values such that the amount use should generally be al least 1.5 times the calculated amount.
  • [0060]
    The photoinitiator and UV absorber are combined with the polymers, monomers or macromers to be polymerized or cross-linked. In one embodiment, the photoinitiator is bound to the macromers. In other embodiments, the photoinitiator remains free in the mixture.
  • [0061]
    While the above illustration is stated in terms of ultraviolet-based initiators and absorbers, the same principles apply to other initiator/absorber combinations. For example, the initiator may be activated by infra-red radiation. In that case, an infra-red absorbing compound must be used to control the activation. The same is true for other stimulus sources, such as light.
  • [0062]
    A key advantage of the optical element of the present invention is that an element property may be modified post-fabrication. In the case of an IOL, for example, the modification may be made after implantation within the eye. For example, any errors in the power calculation due to imperfect corneal measurements and/or variable lens positioning and wound healing may be modified in a post surgical outpatient procedure. Additionally, corrections due to physical changes in the patient over time can also be made.
  • [0063]
    In addition to the change in the element's refractive index, the stimulus-induced formation of the second polymer matrix has been found to affect the element's power by altering the shape of the element in a predictable manner. For example, in one embodiment, formation of the second polymer matrix changes the thermodynamic equilibrium in this element. This in turn promotes the migration of the MC which in turn can cause a change in the curvature of the lens. As a result, both mechanisms may be exploited to modulate an IOL property, such as power, after it has been implanted within the eye. In general, the method for implementing an inventive optical element having a first polymer matrix and a MC dispersed therein comprises:
  • [0064]
    (a) exposing at least a portion of the optical element to a stimulus whereby the stimulus induces the polymerization of the MC. This step may be shipped if the element possesses the desired initial properties;
  • [0065]
    (b) determining that a change in optical properties is required or desired;
  • [0066]
    (c) exposing or reexposing at least a portion of the element to a stimulus whereby the stimulus induces polymerization of the MC to cause a change in optical properties of the element;
  • [0067]
    (d) waiting for a period of time;
  • [0068]
    (e) evaluating the performance of the element.
  • [0069]
    After exposure to an external stimulus, the element may need to be reexposed to stimulus until the desired optical properties are achieved.
  • [0070]
    In another embodiment, wherein an optical element's properties need to be modified, a method for modifying the element comprises:
  • [0071]
    (a) exposing a first portion of the optical element to a stimulus whereby the stimulus induces the polymerization of the MC; and
  • [0072]
    (b) exposing a second portion of the lens to the stimulus.
  • [0073]
    The first element portion and the second element portion represent different regions of the lens although they may overlap. Optionally, the method may include an interval of time between the exposures of the first element portion and the second element portion. In addition, the method may further comprise re-exposing the first element portion and/or the second element portion any number of times (with or without an interval of time between exposures) or may further comprise exposing additional portions of the element (e.g., a third element portion, a fourth element portion, etc.)
  • [0074]
    In general, the location of the one or more exposed portions will vary depending on the type of refractive error being corrected. For example, in one embodiment, the exposed portion of the IOL is the optical zone which is the center region of the lens (e.g., between about 4 mm and about 5 mm in diameter). Alternatively, the one or more exposed lens portions may be along IOL's outer rim or along a particular meridian. In another embodiment, different regions of a spectacle lens can be exposed to a stimulus thereby creating a bifocal spectacle lens. In preferred embodiments, the stimulus is light. In more preferred embodiments, the light is from a laser source.
  • [0075]
    Once the desired correction is made, there is no need for further exposure to the stimulus to “lock in” the shape or properties. The presence of the absorber compound will prevent further changes in the element until the element is exposed to a stimulus of the correct frequency and intensity. This allows the optical element to be used once the initial adjustment is made and, if needed, the optical properties can be readjusted, in situ. In the case of an intraocular lens, this means that after the initial adjustment, the patent can return for future adjustment due to factors such as age or the like, over the life of the lens. In another embodiment, spectacles can be created whose corrective qualities can be repeatedly adjusted, eliminating the need for new lenses as the patient's vision changes.
  • [0076]
    Through the focused use of external stimulus, such as UV light, it is possible to cause polymigration of the MC in specific regions of the optical element. This includes controlling the depth of the second matrix as well as where the matrix is located in relation to the center of the element. FIGS. 3 through 5 illustrate this concept.
  • [0077]
    [0077]FIG. 3 shows a portion of a cross section of an optical element of the invention showing the first polymer matrix, 11 and the modifying composition 12 dispersed within the first polymer matrix.
  • [0078]
    [0078]FIG. 4 reflects the exposure of the optical element to UV light in a predetermined pattern, duration and intensity. The UV absorber in the exposed region prevents polymerization of the MC until the absorption level of the UV absorber is exceeded. Then the inhibitor is triggered resulting in polymerization of the MC to form a second polymer matrix. Formation of the matrix, however, only occurs when the absorbence capacity of the UV absorber has been exceeded. There it is possible to limit the depth of the second polymer matrix by limiting the intensity and duration of the exposure to UV light. FIG. 5 represents such a limited matrix formation. The second polymer matrix only expands part way through the optical element with optical properties different than the unmodified regions. Further exposures of the optical element to UV light can then be used to alter the optical properties further.
  • [0079]
    As noted above, those adjustments can be made during the course of the initial adjustment or can occur weeks or years later. Thus, as the needs of the users change over time, the optical properties can be adjusted without the need for surgery or the like.
  • [0080]
    The readjustable properties of the optical element can also lead to novel data storage devices. By controlling the region where the second polymer matrix is found, it is possible to record data in three dimensions and then add or change the data stored at a later time.
  • [0081]
    Although the present invention and its advantages have been described in detail, it should be understood that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims. Moreover, the scope of the present application is not intended to be limited to the particular embodiments of the process, machine, manufacture, composition of matter, means, methods and steps described in the specification. As one of ordinary skill in the art will readily appreciate from the disclosure of the present invention, processes, machines, manufacture, compositions of matter, means, methods, or steps, presently existing or later to be developed that perform substantially the same function or achieve substantially the same result as the corresponding embodiments described herein may be utilized according to the present invention. Accordingly, the appended claims are intended to include within their scope such processes, machines, manufacture, compositions of matter, means, methods, or steps.
  • EXAMPLES
  • [0082]
    The following examples are offered by way of example and are not intended to limit the scope of the invention in any manner.
  • [0083]
    A series of siloxane slabs were prepared as reflected in the tables below. In the control experiments, Part A consisted of a silicone polymer Silicone MED 6820. Part B was prepared by mixing Silicone 6820 with a catalyst Pt-divinyltetramethyldisiloxane complex. Parts A and B were separately degassed to remove any air and then blended together. The mixture was then degassed and placed into a 1 mm thick mold where it was held in a Carver press for 48 hours at approx. 1000 psi and at 40° C.
  • [0084]
    The experimental sections were prepared in the same manner except that a blend of modifying composition, UV absorber and UV initiator was first prepared and then added to Part A. The proportions of the components were as listed in Table I. The modifying composition (identified as CalAdd in Table I) was methacrylate endcapped dimethylsiloxane diphenylsiloxane copolymer with a Mn of from 700 to 1000.
  • [0085]
    In the table below, the initiators used consisted generally of the following compounds, Irganox 651, a commercially available UV initiator made by Ciba Specialty Chemicals, Inc.; Initiator B-pdms-B which is a blend of dual benzoin structures having the general structure
    Figure US20030174375A1-20030918-C00010
  • [0086]
    wherein n ranges from 2 to 28, and B-L4-B which has the same general structure as above except with n=2 only. Use of these initiators are preferred for applications where clarity is essential such as optical elements. In other applications where clarity is not essential, the use of other initiators such as Irgacure 369 is acceptable. Again, the key is to use an initiator that is triggered in the desire range of wavelengths and does not require an intensity in excess of prescribed safety standards.
  • [0087]
    In the experiments recited in the table below, the ultraviolet absorbing compound used is UVAM a commercially available absorber. While the use of UVAM is preferred, other ultraviolet absorbing compounds may be used.
  • [0088]
    In the experiments reported in Table I, polymer slabs were prepared as described above. Sections of the slab were then taken and exposed to light at 365 nm for 30 to 120 minutes at intensities ranging from 0.0 to 8 milliwatts per square centimeters. The transmission and absorbence of the UV light through the section was determined by Differential Photocalorimetric Analyzer and reported in the table as 10% Transmittance and ΔH (heat of polymerization).
    TABLE I
    Part A Part B Irg 651 B-L4-B B-pdms-B UVAM Cal. Add Intensity ΔH 10%
    Experiment Wt % Wt % Wt % Wt % Wt % Wt % Wt % mW/cm2 Environ. J/g T
    Control 34.9 34.9 0.23 29.97 4.82 N2 −20.584 290 nm
    3.11 Air −18.586
    2 34.9 34.9 0.23 0.04 29.93 4.82 N2 −25.832 384 nm
    3.11 Air −11.575
    3 46.7 33.3 0.23 0.02 19.75 9.61 N2 −6.397 363 nm
    9.7 Air −8.742
    4 46.70 33.3 0.23 0.02 19.75 9.61 N2 −2.839 361 nm
    9.61 Air −8.156
    5 36.3 33.3 0.46 0.02 29.92 6.7 N2 15.631 364
    6.59 Air −21.363
    8.66 Aqueous −25.473
    6.77 −27.273
    6.37 −19.545
    4.33 −23.183
    087 −17.785
    6 36.3 33.2 0.5 0.02 29.98 6.68 N2 −18.36 323
    6.68 Air −13.025
    7 36.2 33.1 0.75 0.03 29.82 7.49 N2 −20.231 364 nm
    3.74 −17.483
    7.49 Air −16.890
    3.74 −2.654
    7.96 Aqueous −19.147
    5.92 −21.672
    3.98 −20.231
    0.796 −21.880
    8 35.2 33.1 .75 .04 29.78 7.86 Air −10.275 383 nm
    9 36.1 33.1 1.0 0.04 29.76 7.86 Air −13.931 383 nm
    8.05 Aqueous −22,899   
    6.26 −18.322
    5.92 −29.994
    4.03 −18710
    0.85 −11.459
    10 36 32.9 1.0 0.04 30.096 6.89 Air −10.015 387 nm
    3.56 −7.835
    3.45 −6.062
    2.07 −3.062
    7.36 Aqueous −20.009
    4.81 −18.071
    2.4 −15.171
    0.74 −11.869
    0.01 −9.219
    11 36 32.9 1.0 0.04 30.096 6.98 Air −11.366 383
    4.01 −9.002
    2.13 −6.163
    .0.71 −1.45
    7.36 Aqueous −14.484
    4.6 −15.295
    2.59 −16.449
    0.74 −13.819
    0.097 −13.819

Claims (8)

    What is claimed is:
  1. 1. An optical element comprising:
    a first polymer matrix;
    a modifying composition dispersed therein, said MC capable of stimulus-induced polymerization;
    a blend of stimulus absorber and stimulus initiator wherein said blend delays the initiation of polymerization until a predetermined level of intensity of stimulus is reached.
  2. 2. The optical element of claim 1 wherein said stimulus is light.
  3. 3. The optical element of claim 2 wherein said stimulus absorber is a light-absorbing compound and said stimulus initiator is a photoinitiator.
  4. 4. The optical element of claim 1 wherein said element is an intraocular lens.
  5. 5. The optical element of claim 1 wherein said optical element is a contact lens.
  6. 6. The optical element of claim 3 wherein said optical element is a spectacle lens.
  7. 7. The optical element of claim 3 wherein said photoabsorber and said photoinitiator is a UV initiator.
  8. 8. The optical element of claim 7 wherein said UV absorber has the general formula:
    Figure US20030174375A1-20030918-C00011
    wherein X is selected from the group consisting of H1 alkoxy radicals, preferably containing 1 to about 6 carbon atoms, R1 is selected from the group consisting of H, alkyl radicals, preferably containing from 1 to 8 carbon atoms, provided that at least one of X and R1 is other than H, R2 is an organic radical with a terminal double bond, and said UV initiator has the general formula:
    Figure US20030174375A1-20030918-C00012
    wherein R1 is an organic radical having a terminal unsaturation; R2 is alkyl, aryl, substituted alkyl or substituted aryl; R3 and R4 are independently selected from phenyls or substituted phenyls.
US10324540 2001-12-28 2002-12-19 Readjustable optical elements Active US6851804B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US34418201 true 2001-12-28 2001-12-28
US10324540 US6851804B2 (en) 2001-12-28 2002-12-19 Readjustable optical elements

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US10324540 US6851804B2 (en) 2001-12-28 2002-12-19 Readjustable optical elements
CN 02828412 CN100497455C (en) 2001-12-28 2002-12-26 Readjustable optical elements
ES02806254T ES2291545T3 (en) 2001-12-28 2002-12-26 resettable optical elements.
PCT/US2002/041609 WO2003058287A8 (en) 2001-12-28 2002-12-26 Optical elements re-adjustable with uv-light
DE2002621902 DE60221902D1 (en) 2001-12-28 2002-12-26 Readjustierbare optical elements
DE2002621902 DE60221902T2 (en) 2001-12-28 2002-12-26 Readjustierbare optical elements
JP2003558542A JP2005514495A (en) 2001-12-28 2002-12-26 Re adjustable optical element
EP20020806254 EP1468044B1 (en) 2001-12-28 2002-12-26 Readjustable optical elements
US10914378 US7074840B2 (en) 2002-12-19 2004-08-09 Light adjustable lenses capable of post-fabrication power modification via multi-photon processes
US11256137 US7237893B2 (en) 2001-12-28 2005-10-21 Light adjustable lenses capable of post-fabrication power modification via multi-photon processes

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10914378 Continuation-In-Part US7074840B2 (en) 2001-12-28 2004-08-09 Light adjustable lenses capable of post-fabrication power modification via multi-photon processes
US11256137 Continuation-In-Part US7237893B2 (en) 2001-12-28 2005-10-21 Light adjustable lenses capable of post-fabrication power modification via multi-photon processes

Publications (2)

Publication Number Publication Date
US20030174375A1 true true US20030174375A1 (en) 2003-09-18
US6851804B2 US6851804B2 (en) 2005-02-08

Family

ID=28044848

Family Applications (1)

Application Number Title Priority Date Filing Date
US10324540 Active US6851804B2 (en) 2001-12-28 2002-12-19 Readjustable optical elements

Country Status (7)

Country Link
US (1) US6851804B2 (en)
EP (1) EP1468044B1 (en)
JP (1) JP2005514495A (en)
CN (1) CN100497455C (en)
DE (2) DE60221902D1 (en)
ES (1) ES2291545T3 (en)
WO (1) WO2003058287A8 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040049174A1 (en) * 2000-03-21 2004-03-11 Peyman Gholam A. Adjustable inlay with multizone polymerization
US20050182489A1 (en) * 2001-04-27 2005-08-18 Peyman Gholam A. Intraocular lens adapted for adjustment via laser after implantation
WO2006135572A1 (en) * 2005-06-10 2006-12-21 Calhoun Vision, Inc. Initiator and ultraviolet absorber for changing lens power by ultraviolet light
US20070055369A1 (en) * 2005-09-08 2007-03-08 Calhoun Vision, Inc Novel adjustable optical elements with enhanced ultraviolet protection
US20090118828A1 (en) * 2007-11-06 2009-05-07 Altmann Griffith E Light-adjustable multi-element ophthalmic lens
US20100305693A1 (en) * 2004-08-27 2010-12-02 Brown David C Devices, Systems and Methods for Treating an Eye
US8752958B2 (en) 1999-03-01 2014-06-17 Boston Innovative Optics, Inc. System and method for increasing the depth of focus of the human eye
US20150280151A1 (en) * 2014-03-28 2015-10-01 Samsung Sdi Co., Ltd. Composition for encapsulation of organic light emitting diode and organic light emitting diode display manufactured using the same
US9204962B2 (en) 2013-03-13 2015-12-08 Acufocus, Inc. In situ adjustable optical mask
US9427922B2 (en) 2013-03-14 2016-08-30 Acufocus, Inc. Process for manufacturing an intraocular lens with an embedded mask
US9545303B2 (en) 2011-12-02 2017-01-17 Acufocus, Inc. Ocular mask having selective spectral transmission

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6450642B1 (en) * 1999-01-12 2002-09-17 California Institute Of Technology Lenses capable of post-fabrication power modification
US20050113911A1 (en) * 2002-10-17 2005-05-26 Peyman Gholam A. Adjustable intraocular lens for insertion into the capsular bag
US8162927B2 (en) * 2000-03-21 2012-04-24 Gholam A. Peyman Method and apparatus for accommodating intraocular lens
US7237893B2 (en) * 2001-12-28 2007-07-03 Chang Shiao H Light adjustable lenses capable of post-fabrication power modification via multi-photon processes
DE60306203D1 (en) * 2003-01-09 2006-07-27 Alcon Inc lentils dual function UV absorber materials for ophthalmic
US20060027939A1 (en) 2004-08-03 2006-02-09 Axel Brait Method for making novel compositions capable of post fabrication modification
CN101203192B (en) 2005-03-30 2010-09-15 纽镜有限公司 Adjustable intraocular lens assembly and separation element
US20070031473A1 (en) * 2005-08-05 2007-02-08 Peyman Gholam A Drug delivery system and method
US20070100443A1 (en) * 2005-10-27 2007-05-03 Peyman Gholam A Intraocular lens adapted for accommodation via electrical signals
US9681800B2 (en) 2005-10-27 2017-06-20 The Arizona Board Of Regents On Behalf Of The University Of Arizona Holographic adaptive see-through phoropter
US20080001320A1 (en) * 2006-06-28 2008-01-03 Knox Wayne H Optical Material and Method for Modifying the Refractive Index
US20080027537A1 (en) * 2006-07-26 2008-01-31 Calhoun Vision, Inc. Method for improved retinal safety using the light adjustable lens (LAL)
US20080103592A1 (en) * 2006-10-30 2008-05-01 Calhoun Vision, Inc. Piggyback lenses
US9417464B2 (en) 2008-08-20 2016-08-16 Johnson & Johnson Vision Care, Inc. Method and apparatus of forming a translating multifocal contact lens having a lower-lid contact surface
US8317505B2 (en) 2007-08-21 2012-11-27 Johnson & Johnson Vision Care, Inc. Apparatus for formation of an ophthalmic lens precursor and lens
US8313828B2 (en) * 2008-08-20 2012-11-20 Johnson & Johnson Vision Care, Inc. Ophthalmic lens precursor and lens
US9717589B2 (en) 2007-10-15 2017-08-01 Akkolens International B.V. Adjustable accommodating intraocular lens and positioning means
CA2754775C (en) * 2009-03-04 2016-09-27 Aaren Scientific Inc. System for characterizing a cornea and obtaining an ophthalmic lens
US8646916B2 (en) 2009-03-04 2014-02-11 Perfect Ip, Llc System for characterizing a cornea and obtaining an opthalmic lens
US8292952B2 (en) 2009-03-04 2012-10-23 Aaren Scientific Inc. System for forming and modifying lenses and lenses formed thereby
EP2591043B1 (en) * 2010-07-07 2017-05-24 California Institute of Technology On-demand photoinitiated polymerization
WO2012106673A1 (en) 2011-02-04 2012-08-09 Forsight Labs, Llc Intraocular accommodating lens
RU2495615C1 (en) * 2012-07-11 2013-10-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт глазных болезней" Российской академии медицинских наук (ФГБУ "НИИГБ" РАМН) Method of calculating optic power of iol in children of early age with congenital monocular cataract

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3741628A (en) * 1967-10-19 1973-06-26 J Margerum Method of controlling the intensity of a light beam using photochromic compounds
US4148987A (en) * 1977-05-04 1979-04-10 Rohm And Haas Company Radiation-curable monomers and polymers thereof
US4719248A (en) * 1985-08-08 1988-01-12 Bausch & Lomb Incorporated Ultraviolet blocking agents for contact lenses
US5098445A (en) * 1989-03-14 1992-03-24 Ciba-Geigy Corporation Ultraviolet radiation absorbing agent for bonding to an ocular lens
US5534558A (en) * 1991-06-24 1996-07-09 Polaroid Corporation Process and composition for cladding optical fibers
US5621017A (en) * 1994-04-27 1997-04-15 Tokuyama Corporation Photochromic composition and method producing photochromic cured product
US5891931A (en) * 1997-08-07 1999-04-06 Alcon Laboratories, Inc. Method of preparing foldable high refractive index acrylic ophthalmic device materials
US5989462A (en) * 1997-07-31 1999-11-23 Q2100, Inc. Method and composition for producing ultraviolent blocking lenses
US6132462A (en) * 1995-12-22 2000-10-17 Santen Pharmaceutical Co., Ltd. Copolymers formed from three components and intraocular lenses made thereof
US6218463B1 (en) * 1998-04-20 2001-04-17 Johnson & Johnson Vision Care, Inc. Ocular devices manufactured with free radical-polymerizable latent ultra-violet absorbers
US6465588B1 (en) * 1997-10-07 2002-10-15 Santen Pharmaceutical Co., Ltd. Four component copolymers and the ocular lens made thereof
US20030125409A1 (en) * 2001-11-02 2003-07-03 Yu-Chin Lai Method for polymerizing lenses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6244707B1 (en) 1998-07-21 2001-06-12 Wesley Jessen Corporation UV blocking lenses and material containing benzotriazoles and benzophenones
JP3677240B2 (en) * 2000-03-20 2005-07-27 カリフォルニア インスティテュート オブ テクノロジー Application of wavefront sensor to capable magnification adjusted after manufacture lenses
CA2445304A1 (en) * 2001-03-21 2002-10-03 Calhoun Vision Composition and method for producing shapable implants in vivo and implants produced thereby
US20030176521A1 (en) * 2001-12-28 2003-09-18 Calhoun Vision Initiator and ultraviolet absorber for changing lens power by ultraviolet light

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3741628A (en) * 1967-10-19 1973-06-26 J Margerum Method of controlling the intensity of a light beam using photochromic compounds
US4148987A (en) * 1977-05-04 1979-04-10 Rohm And Haas Company Radiation-curable monomers and polymers thereof
US4719248A (en) * 1985-08-08 1988-01-12 Bausch & Lomb Incorporated Ultraviolet blocking agents for contact lenses
US5098445A (en) * 1989-03-14 1992-03-24 Ciba-Geigy Corporation Ultraviolet radiation absorbing agent for bonding to an ocular lens
US5534558A (en) * 1991-06-24 1996-07-09 Polaroid Corporation Process and composition for cladding optical fibers
US5621017A (en) * 1994-04-27 1997-04-15 Tokuyama Corporation Photochromic composition and method producing photochromic cured product
US6132462A (en) * 1995-12-22 2000-10-17 Santen Pharmaceutical Co., Ltd. Copolymers formed from three components and intraocular lenses made thereof
US5989462A (en) * 1997-07-31 1999-11-23 Q2100, Inc. Method and composition for producing ultraviolent blocking lenses
US5891931A (en) * 1997-08-07 1999-04-06 Alcon Laboratories, Inc. Method of preparing foldable high refractive index acrylic ophthalmic device materials
US6465588B1 (en) * 1997-10-07 2002-10-15 Santen Pharmaceutical Co., Ltd. Four component copolymers and the ocular lens made thereof
US6218463B1 (en) * 1998-04-20 2001-04-17 Johnson & Johnson Vision Care, Inc. Ocular devices manufactured with free radical-polymerizable latent ultra-violet absorbers
US20030125409A1 (en) * 2001-11-02 2003-07-03 Yu-Chin Lai Method for polymerizing lenses

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8752958B2 (en) 1999-03-01 2014-06-17 Boston Innovative Optics, Inc. System and method for increasing the depth of focus of the human eye
US7001374B2 (en) 2000-03-21 2006-02-21 Minu, L.L.C. Adjustable inlay with multizone polymerization
US20040049174A1 (en) * 2000-03-21 2004-03-11 Peyman Gholam A. Adjustable inlay with multizone polymerization
US20050182489A1 (en) * 2001-04-27 2005-08-18 Peyman Gholam A. Intraocular lens adapted for adjustment via laser after implantation
US20100305693A1 (en) * 2004-08-27 2010-12-02 Brown David C Devices, Systems and Methods for Treating an Eye
WO2006135572A1 (en) * 2005-06-10 2006-12-21 Calhoun Vision, Inc. Initiator and ultraviolet absorber for changing lens power by ultraviolet light
US20070055369A1 (en) * 2005-09-08 2007-03-08 Calhoun Vision, Inc Novel adjustable optical elements with enhanced ultraviolet protection
US9119710B2 (en) * 2005-09-08 2015-09-01 Calhoun Vision, Inc. Adjustable optical elements with enhanced ultraviolet protection
US20090118828A1 (en) * 2007-11-06 2009-05-07 Altmann Griffith E Light-adjustable multi-element ophthalmic lens
US9545303B2 (en) 2011-12-02 2017-01-17 Acufocus, Inc. Ocular mask having selective spectral transmission
US9204962B2 (en) 2013-03-13 2015-12-08 Acufocus, Inc. In situ adjustable optical mask
US9603704B2 (en) 2013-03-13 2017-03-28 Acufocus, Inc. In situ adjustable optical mask
US9427922B2 (en) 2013-03-14 2016-08-30 Acufocus, Inc. Process for manufacturing an intraocular lens with an embedded mask
US20150280151A1 (en) * 2014-03-28 2015-10-01 Samsung Sdi Co., Ltd. Composition for encapsulation of organic light emitting diode and organic light emitting diode display manufactured using the same
US9893307B2 (en) * 2014-03-28 2018-02-13 Samsung Sdi Co., Ltd. Composition for encapsulation of organic light emitting diode and organic light emitting diode display manufactured using the same

Also Published As

Publication number Publication date Type
EP1468044A4 (en) 2005-07-13 application
WO2003058287A2 (en) 2003-07-17 application
ES2291545T3 (en) 2008-03-01 grant
US6851804B2 (en) 2005-02-08 grant
WO2003058287A3 (en) 2003-09-18 application
DE60221902D1 (en) 2007-09-27 grant
WO2003058287A8 (en) 2004-01-29 application
CN1622969A (en) 2005-06-01 application
JP2005514495A (en) 2005-05-19 application
DE60221902T2 (en) 2008-05-15 grant
CN100497455C (en) 2009-06-10 grant
EP1468044A2 (en) 2004-10-20 application
EP1468044B1 (en) 2007-08-15 grant

Similar Documents

Publication Publication Date Title
US6599317B1 (en) Intraocular lens with a translational zone
US6361561B1 (en) Injectable intraocular lens
US5331073A (en) Polymeric compositions and intraocular lenses made from same
US6281319B1 (en) Water plasticized high refractive index polymer for ophthalmic applications
US6140438A (en) Soft intraocular lens material
US6645246B1 (en) Intraocular lens with surrounded lens zone
US6036891A (en) Polymerizable hydrophilic ultraviolet light absorbing monomers
US20050027354A1 (en) Primary and supplemental intraocular lens
US7033391B2 (en) High refractive index silicone-containing prepolymers with blue light absorption capability
US20050143812A1 (en) Intraocular lenses having a visible light-selective-transmissive-region
US20070092831A1 (en) Radiation-absorbing polymeric materials and ophthalmic devices comprising same
US7098283B2 (en) Reactive yellow dyes useful for ocular devices
US6027745A (en) Process for producing controlled drug-release contact lens, and controlled drug-release contact lens thereby produced
US7101949B2 (en) High refractive index polymeric siloxysilane compositions
US20020049290A1 (en) High refractive index hydrogel compositions for ophthalmic implants
US20080306587A1 (en) Lens Material and Methods of Curing with UV Light
US20080027537A1 (en) Method for improved retinal safety using the light adjustable lens (LAL)
US6432137B1 (en) High refractive index silicone for use in intraocular lenses
US6679605B2 (en) Crystalline polymeric compositions for ophthalmic devices
US6613343B2 (en) Injectable intraocular accommodating lens
US6326448B1 (en) Soft intraocular lens material
US20050055090A1 (en) Process for manufacturing intraocular lenses with blue light absorption characteristics
US20040056371A1 (en) Method of manufacturing ophthalmic lenses made from hydrophobic acrylic polymers
US6852793B2 (en) Low water content, high refractive index, flexible, polymeric compositions
US6066172A (en) Injectable intraocular lens

Legal Events

Date Code Title Description
AS Assignment

Owner name: CALHOUN VISION, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JETHMALANI, JAGDISH M.;CHANG, SHIAO H.;REEL/FRAME:013994/0176

Effective date: 20030417

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: RXSIGHT, INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:CALHOUN VISION, INC.;REEL/FRAME:042260/0475

Effective date: 20161018

CC Certificate of correction
PTEF Application for a patent term extension

Free format text: PRODUCT NAME: LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE; REQUESTED FOR 5 YEARS

Filing date: 20180119

Expiry date: 20221219